1. 5-Methoxyleoligin, a lignan from Edelweiss, stimulates CYP26B1-dependent angiogenesis in vitro and induces arteriogenesis in infarcted rat hearts in vivo.
- Author
-
Messner B, Kern J, Wiedemann D, Schwaiger S, Türkcan A, Ploner C, Trockenbacher A, Aumayr K, Bonaros N, Laufer G, Stuppner H, Untergasser G, and Bernhard D
- Subjects
- Animals, Arterioles enzymology, Arterioles growth & development, Arterioles pathology, Arterioles physiopathology, Chick Embryo, Coronary Circulation drug effects, Coronary Vessels enzymology, Coronary Vessels pathology, Coronary Vessels physiopathology, Disease Models, Animal, Human Umbilical Vein Endothelial Cells, Humans, Lignans chemistry, Male, Myocardium pathology, Rats, Rats, Wistar, Retinoic Acid 4-Hydroxylase, Ventricular Function, Left drug effects, Asteraceae chemistry, Cytochrome P-450 Enzyme System metabolism, Lignans pharmacology, Myocardial Infarction drug therapy, Myocardial Infarction enzymology, Myocardial Infarction pathology, Myocardial Infarction physiopathology, Myocardium enzymology, Neovascularization, Physiologic drug effects
- Abstract
Background: Insufficient angiogenesis and arteriogenesis in cardiac tissue after myocardial infarction (MI) is a significant factor hampering the functional recovery of the heart. To overcome this problem we screened for compounds capable of stimulating angiogenesis, and herein investigate the most active molecule, 5-Methoxyleoligin (5ML), in detail., Methods and Results: 5ML potently stimulated endothelial tube formation, angiogenic sprouting, and angiogenesis in a chicken chorioallantoic membrane assay. Further, microarray- and knock down- based analyses revealed that 5ML induces angiogenesis by upregulation of CYP26B1. In an in vivo rat MI model 5ML potently increased the number of arterioles in the peri-infarction and infarction area, reduced myocardial muscle loss, and led to a significant increase in LV function (plus 21% 28 days after MI)., Conclusion: The present study shows that 5ML induces CYP26B1-dependent angiogenesis in vitro, and arteriogenesis in vivo. Whether or not CYP26B1 is relevant for in vivo arteriogenesis is not clear at the moment. Importantly, 5ML-induced arteriogenesis in vivo makes the compound even more interesting for a post MI therapy. 5ML may constitute the first low molecular weight compound leading to an improvement of myocardial function after MI.
- Published
- 2013
- Full Text
- View/download PDF